Jin Ding
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Hepatology 32
- Hepatocellular Carcinoma Treatment and Prognosis 27
- Liver physiology and pathology 10
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
- NF-κB Signaling Pathways 4
- Co-authors
- Hongyang Wang (31 shared papers)Beifang Ning (19 shared papers)Wei‐Fen Xie (17 shared papers)Wen Ce Sun (20 shared papers)Daimin Xiang (11 shared papers)Zhuo Cheng (11 shared papers)Tao Han (9 shared papers)Cheng Yeh Chen (7 shared papers)
- Journals
- Hepatology (8 papers)Journal of Hepatology (6 papers)Cancer Letters (5 papers)Journal of Biological Chemistry (4 papers)Cancer Research (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jin Ding
97 papers receiving 6.3k citations
Jin Ding's Hit Papers
Peers
Comparison fields: 5 of 105
- Hepatology 1.2k
- Cancer Research 1.8k
- Oncology 847
- Molecular Biology 2k
- Immunology 212
Countries citing papers authored by Jin Ding
This map shows the geographic impact of Jin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Ding more than expected).
Fields of papers citing papers by Jin Ding
This network shows the impact of papers produced by Jin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Ding. The network helps show where Jin Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Jin Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA Hit paper breakdown → | 2016 | 938 |
| 2 | 2011 | 296 | |
| 3 | 2016 | 267 | |
| 4 | Glycogen accumulation and phase separation drives liver tumor initiation Hit paper breakdown → | 2021 | 245 |
| 5 | 2010 | 209 | |
| 6 | 2008 | 205 | |
| 7 | 2016 | 198 | |
| 8 | 2016 | 198 | |
| 9 | 2017 | 197 | |
| 10 | 2012 | 181 | |
| 11 | 2017 | 156 | |
| 12 | 2019 | 141 | |
| 13 | 2016 | 133 | |
| 14 | 2015 | 128 | |
| 15 | 2018 | 110 | |
| 16 | 2019 | 110 | |
| 17 | 2018 | 108 | |
| 18 | 2017 | 107 | |
| 19 | 2020 | 102 | |
| 20 | 2014 | 96 |
About Jin Ding
Jin Ding is a scholar working on Hepatology, Cancer Research, Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 103 papers that have together received 6.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Liver physiology and pathology (10 papers), Cancer Cells and Metastasis (8 papers), MicroRNA in disease regulation (8 papers), Signaling Pathways in Disease (6 papers), Cancer-related molecular mechanisms research (6 papers), Protein Tyrosine Phosphatases (4 papers) and NF-κB Signaling Pathways (4 papers). The work is most often cited by research in Hepatology (1.2k citations), Cancer Research (1.8k citations), Oncology (847 citations), Molecular Biology (2k citations) and Immunology (212 citations). Jin Ding has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hongyang Wang, Beifang Ning, Wei‐Fen Xie, Wen Ce Sun, Daimin Xiang, Zhuo Cheng, Tao Han, Cheng Yeh Chen, Gen‐Sheng Feng and Kun Wu. Their work appears in journals such as Hepatology, Journal of Hepatology, Cancer Letters, Journal of Biological Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.